EX-FILING FEES 2 a1071s-8xfeetableexhibit1.htm EX-FILING FEES

Document

Exhibit 107.1

Calculation of Filing Fee Table

Form S-8

(Form Type)

Daré Bioscience, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

Security type			Security class title			Fee calculation rule			Amount registered (1)			Proposed maximum offering price per unit (2)						Maximum aggregate offering price			Fee rate			Amount of registration fee
Equity			Common Stock, $0.0001 par value per share			Other			475,000			$1.26			(3)			$600,305			$92.70 per $1,000,000			$56
Equity			Common Stock, $0.0001 par value per share			Other			15,718,758			$1.14			(4)			$17,919,384			$92.70 per $1,000,000			$1,661
Total Offering Amounts																		$18,519,689						$1,717
Total Fee Offsets																								—
Net Fee Due																								$1,717

(1)Pursuant to Rule 416 under the Securities Act of 1933, this registration statement also covers such number of additional shares of common stock that may become issuable under the Daré Bioscience, Inc. 2022 Stock Incentive Plan (the “Plan”) by reason of any stock split, stock dividend, recapitalization, or any other similar transaction effected that results in an increase to the number of outstanding shares of the registrant’s common stock. The shares being registered consist of (a) 475,000 shares (the “Shares Subject to Outstanding Options”) subject to outstanding options granted under the Plan and (b) 15,718,758 shares reserved for future grant or issuance under the Plan (the "Reserved Shares").

(2)Estimated solely for the purpose of computing the registration fee in accordance with Rules 457(c) and 457(h) under the Securities Act of 1933.

(3)The proposed maximum offering price per share for the Shares Subject to Outstanding Options is based upon the weighted-average exercise price of the outstanding options.

(4)The proposed maximum offering price per share for the Reserved Shares are based on the average of the high and the low prices per share of the registrant’s common stock as reported on the Nasdaq Capital Market as of a date (August 3, 2022) within five business days prior to the filing of this registration statement.